Assoc. Prof. HALE GÖKCAN

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone

Duman S., Kuru D., Gumussoy M., KİREMİTCİ S., GÖKCAN H., Ulas B., et al.

EUROPEAN RADIOLOGY , vol.34, no.6, pp.3882-3888, 2024 (SCI-Expanded)

Multidrug-Resistant Infections After Liver Transplantation, Etiology and Risk Factors: A Single-Center Experience

Tezcan H., Altunsoy A., Gokce D. T., GÖKCAN H., Ari D., Aydin O., et al.

EXPERIMENTAL AND CLINICAL TRANSPLANTATION , vol.21, no.12, pp.952-960, 2023 (SCI-Expanded)

Development of metabolic disorders in transplant recipients

Erdemir G., GÖKCAN H., GÜRSOY ÇORUH A., GÜLPINAR B., Ellik Z. M., Gumussoy M., et al.

JOURNAL OF HEPATOLOGY , vol.78, 2023 (SCI-Expanded)

Effect of Pretransplant Sarcopenia on Mortality in Liver Transplant Recipients

Arı D., Dağlı M., GÖKCAN H., Gökçe D. T., Ökten R. S., Aydın O., et al.

Experimental and Clinical Transplantation , vol.21, no.2, pp.123-131, 2023 (SCI-Expanded)

Management of Biliary Complications in Liver Transplant Recipients with Duct-To-Duct Anastomosis: A Single-Center Experience

KARAKAYA M. F., Er E., Kırımker O., Gümüşsoy M., BODAKÇİ E., Özercan M., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.2, pp.177-181, 2023 (SCI-Expanded)

Complete Recovery After Immunosuppressive Treatment Change in a Patient With Posttransplant Lymphoproliferative Disorder

Arı D., Turan D., GÖKCAN H., Özdemir M., Kayhan M. A.

Experimental and Clinical Transplantation , vol.21, no.1, pp.76-79, 2023 (SCI-Expanded)

Factors associated with the development of extrahepatic malignancy in patients with nonalcoholic fatty liver disease: a single-center longitudinal study

Gumussoy M., Koc O., KARATAŞ G., Ozercan M., Ellik Z., DUMAN S., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.34, no.11, pp.1172-1177, 2022 (SCI-Expanded)

NATURAL DISEASE OUTCOMES IN PATIENT WITH NONALCOHOLIC FATTY LIVER DISEASE: A STUDY WITH PAIRED LIVER BIOPSIES

Gumussoy M., Gokce D. T., Ekelik M., KİREMİTCİ S., Bodakci E., DUMAN S., et al.

HEPATOLOGY , vol.76, 2022 (SCI-Expanded)

Effectiveness of MRI methods in the assessment of hepatic steatosis in living liver donors

KURU ÖZ D., Ellik Z. M., Coruh A. G., ADIGÜZEL M., Gumussoy M., DUMAN S., et al.

JOURNAL OF HEPATOLOGY , vol.77, 2022 (SCI-Expanded)

Role of hepatosteatosis in HBsAg seroconversion in HBeAg-negative chronic hepatitis B patients

Bacaksiz F., GÖKCAN H., Akdogan M., Gokce D. T., Ari D., Gokbulut V., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.12, 2021 (SCI-Expanded)

Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation

AKARSU M., Onem S., TURAN İ., Adali G., Akdogan M., Akyildiz M., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.32, no.9, pp.712-719, 2021 (SCI-Expanded) Sustainable Development

Association between non-alcoholic fatty liver disease and extrahepatic malignancy

Gumussoy M., İDİLMAN R., GÖKCAN H., Gokce D. T., Ulas B. B., Koc O., et al.

JOURNAL OF HEPATOLOGY , vol.75, 2021 (SCI-Expanded)

Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience

Degertekin B., DEMİR M., AKARCA U. S., Kani H. T., ÜÇBİLEK E., Yildirim E., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.31, no.12, pp.883-893, 2020 (SCI-Expanded)

Effects of preoperative endoscopic pneumatic balloon dilatation on postoperative achalasia symptoms after Heller esophageal myotomy plus Dor fundoplication

Gokcan H.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.29, no.5, pp.526-529, 2018 (SCI-Expanded)

Prognostic Utility of Hypokalemia in Cirrhotic Patients

Kaplan M., Ates I., Gokcan H., Kayhan M. A., Kacari S., Akpinar M. Y., et al.

ACTA GASTRO-ENTEROLOGICA BELGICA , no.3, pp.398-403, 2018 (SCI-Expanded)

Pregabalin: A New Adjunct in Calcineurin Inhibitor Pain Syndrome Treatment

Tasoglu O., Gokcan H., Demir S. O., Yenigun D., Akdogan M., Kacar S.

PROGRESS IN TRANSPLANTATION , vol.26, no.3, pp.224-226, 2016 (SCI-Expanded)

GASTROINTESTINAL STROMAL TUMOR IN A YOUNG MAN WITH SEVERE HEMATEMESIS : A CASE STUDY

kuzu U. B., Suna N., Torun S., Gokcan H., Oztas E., Odemis B.

GASTROENTEROLOGY NURSING , vol.39, no.5, pp.397-399, 2016 (SCI-Expanded)

Case of a successful liver transplantation from a living donor with focal nodular hyperplasia

Gokcan H., Akdogan M., Kacar S., Okten R. S., Ozdemir M., Turhan N., et al.

ACTA GASTRO-ENTEROLOGICA BELGICA , vol.79, no.2, pp.262-263, 2016 (SCI-Expanded)

The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C

Gokcan H., Kuzu U. B., Oztas E., Saygili F., Oztuna D., Suna N., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , no.2, pp.156-164, 2016 (SCI-Expanded)

Different bismuth-based therapies for eradicating Helicobacter pylori: Randomized clinical trial of efficacy and safety

Gokcan H., Oztas E., Onal I. K.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , vol.40, no.1, pp.124-131, 2016 (SCI-Expanded)

Predictors of Survival in Hepatocellular Carcinoma Patients

Gokcan H., Savas N., Oztuna D., Moray G., Boyvat F., HABERAL M.

ANNALS OF TRANSPLANTATION , pp.596-603, 2015 (SCI-Expanded)

Predictive Value of Unenhanced Computerized Tomography for Detecting Hepatosteatosis in Living Liver Donors

Kuzu U. B., Gokcan H., Suna N., Ozdemir M., Yildiz H., Kacar S., et al.

TRANSPLANTATION PROCEEDINGS , no.6, pp.1854-1859, 2015 (SCI-Expanded)

Fractalkine receptor polymorphism may not be associated with the development and clinical course of ulcerative colitis

Gokcan H., Yurtcu E., Selcuk H., Sahin F. I.

BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES , vol.15, no.2, pp.73-77, 2015 (SCI-Expanded)

The Nutritional Risk Screening 2002 tool for detecting malnutrition risk in hospitalised patients: Perspective from a developing country

Gokcan H., Selcuk H., Tore E., Gulseren P., Cambaz H., Saritas S., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.25, no.6, pp.718-723, 2014 (SCI-Expanded) Sustainable Development

What is the impact of Helicobacter pylori density on the success of eradication therapy: A clinico-histopathological study

Onal I. K., Gokcan H., Benzer E., Bilir G., Oztas E.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , vol.37, no.6, pp.642-646, 2013 (SCI-Expanded)

A case of eosinophilic gastritis secondary to ulcerative colitis

Gokcan H., Uruc I., Selcuk H., Savas N., Yilmaz U.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.21, no.1, pp.69-70, 2010 (SCI-Expanded)

Detection of MEFV Gene Mutations in Patients with Inflammatory Bowel Disease

Yurtcu E., Gokcan H., Yilmaz U., ŞAHİN F. İ.

GENETIC TESTING AND MOLECULAR BIOMARKERS , vol.13, no.1, pp.87-90, 2009 (SCI-Expanded)

Total colonic polyp diameter: A marker for the risk of malignancy?

Selcuk H., Korkmaz M., Kanbay M., Tore E., Sumer H., UNAL H. U., et al.

HEPATO-GASTROENTEROLOGY , vol.55, no.84, pp.936-939, 2008 (SCI-Expanded)

Dipeptidyl peptidase IV (DDP IV) in NASH patients

BALABAN H. Y., KORKUSUZ P., Simsek H., Gokcan H., Gedikoglu G., Pinar A., et al.

ANNALS OF HEPATOLOGY , vol.6, no.4, pp.242-250, 2007 (SCI-Expanded)

Malignancy risk of small polyps and related factors

UNAL H. U., Selcuk H., Gokcan H., Tore E., Sar A., Korkmaz M., et al.

DIGESTIVE DISEASES AND SCIENCES , vol.52, no.10, pp.2796-2799, 2007 (SCI-Expanded)

<i>HFE</i> mutations analysis of Turkish patients with nonalcoholic steatohepatitis

Simsek H., BALABAN H. Y., Sumer H., Yilmaz E., Tatar G.

DIGESTIVE DISEASES AND SCIENCES , no.10, pp.1723-1724, 2006 (SCI-Expanded)

Mutations of the HFE gene among Turkish hereditary hemochromatosis patients

Simsek H., BALABAN H. Y., Yilmaz E., Sumer H., Buyukasik Y., Cengiz C., et al.

ANNALS OF HEMATOLOGY , vol.84, no.10, pp.646-649, 2005 (SCI-Expanded)

Bone marrow embolism after bone marrow aspiration and biopsy

Önal I., Sümer H., TUFAN A., Shorbagi A.

AMERICAN JOURNAL OF HEMATOLOGY , vol.78, no.2, pp.158, 2005 (SCI-Expanded)

Frequency of HFE mutations among Turkish blood donors according to transferrin saturation

Simsek H., Sumer H., Yilmaz E., BALABAN H. Y., Ozcebe O., Hascelik G., et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY , vol.38, no.8, pp.671-675, 2004 (SCI-Expanded)

Articles Published in Other Journals

A brief communication of patients with homozygous C282Y mutation-related hereditary hemochromatosis

GÖKCAN H., Oz D., BODAKÇİ E., TUNÇ E., İDİLMAN R.

HEPATOLOGY FORUM , vol.5, no.3, pp.161-164, 2024 (ESCI)

Changing trends in the etiology of liver transplantation in Turkiye: A multicenter study

Akarsu M., DOLU S., Harputluoglu M., YILMAZ S., Akyildiz M., Gencdal G., et al.

Hepatology Forum , vol.5, no.1, pp.3-6, 2024 (Scopus)

Pancreatic metastasis of renal cell carcinoma: case report

Gökcan H.

Journal of Current Hematology & Oncology Research , vol.1, no.4, pp.109-110, 2023 (Peer-Reviewed Journal)

Hepatoselüler kanser, Güncel yenilikler

GÖKCAN H.

Güncel Gastroenteroloji , vol.25, no.2, pp.75-89, 2023 (Peer-Reviewed Journal)

Post traumatic volvulus: a case report

Gökcan H.

Journal of Comprehensive Surgery , vol.1, pp.60-62, 2023 (Peer-Reviewed Journal)

TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.

YILMAZ Y., ZEYBEL M., ADALI G., COŞAR A., SERTESEN E., SÜMER H., et al.

Hepatology forum , vol.4, no.Suppl 1, pp.1-32, 2023 (ESCI)

The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort

Yaras S., Demir M., Barutcu S., Yildirim A. E., GÜREL S., Ucbilek E., et al.

Hepatology Forum , vol.4, no.3, pp.92-96, 2023 (Scopus)

Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis

Gokce D. T., Ari D., GÖKCAN H., Aydin O., Turhan N., Kayhan M. A.

HEPATOLOGY FORUM , vol.4, no.1, pp.35-36, 2023 (ESCI)

The changing non-invasive fibrosis index value in patients with hepatitis C treated with direct-acting antiviral agents

Ari D., Gökçe D. T., Gökcan H., Öztürk Ö., Bacaksiz F., Kacar S., et al.

Akademik Gastroenteroloji Dergisi , vol.21, no.3, pp.109-114, 2022 (Peer-Reviewed Journal)

Characteristics of patients with hepatocellular carcinoma: A multicenter study

Guzelbulut F., KARAOĞULLARINDAN Ü., AKKIZ H., ALTINTAŞ E., DEMİRTAŞ C. Ö., Bahadir O., et al.

HEPATOLOGY FORUM , vol.3, no.3, pp.71-76, 2022 (ESCI)

NSAID-associated drug-induced liver injury prior to and following liver transplantation

Gumussoy M., GÖKCAN H., BODAKÇİ E., KİREMİTCİ S., SAVAŞ B., İDİLMAN R.

HEPATOLOGY FORUM , vol.3, no.3, pp.108-109, 2022 (ESCI)

Our Experience with Patients That Diagnosed Ischemic Colitis in Colonoscopy

Gökbulut V., Kaplan M., Disibeyaz S., Kacar S., Gökcan H., Gökbulut P., et al.

Journal of Contemporary Medicine , vol.12, no.1, pp.38-43, 2022 (Peer-Reviewed Journal)

Evaluation of esophageal motor functions in patients diagnosed with primary biliary cholangitis, primary sclerosing cholangitis and autoimmune hepatitis

Gokbulut V., Ozturk O., Akdogan M., Kaplan M., GÖKCAN H., Kacar S., et al.

CUKUROVA MEDICAL JOURNAL , vol.47, no.1, pp.21-28, 2022 (ESCI)

HBV/HDV management after liver transplantation: Review

Muhammad H., Zaffar D., Tehreem A., Peng-Sheng T., ŞİMŞEK C., GÖKCAN H., et al.

Journal of Liver Transplantation , 2021 (Peer-Reviewed Journal)

Hepatitis D Infection in Asia: A Perspective From an Endemic Region

GÖKCAN H., İDİLMAN R.

Clinical Liver Disease , vol.18, no.1, pp.26-29, 2021 (Scopus) Sustainable Development

The Prevalence of Metabolic Associated Fatty Liver Disease in The Turkish Population: A Multicenter Study

YILMAZ Y., YILMAZ N., ATEŞ F., KARAKAYA M. F., GÖKCAN H., KAYA E., et al.

Hepatology forum , vol.2, no.2, pp.37-42, 2021 (ESCI)

Gastrointestinal Subepitelyal Lezyonlarda Tedavi ve İzlem Algoritmi Treatment and Monitoring of Gastrointestinal Subepitelial Lesions

ARI D., GÖKCAN H., AKDOĞAN KAYHAN M.

Türkiye Klinikleri Gastroenterohepatoloji Dergisi , pp.72-76, 2020 (Non Peer-Reviewed Journal)

Effectiveness of Technetium-99 m monoclonal antibody scintigraphy for the detection of infectious focus in a case series in cirrhotic patients

GÖKCAN H., AKTAŞ A., ÖZTÜRK Ö., SAVAŞ N.

Hepatology forum , vol.2, no.1, pp.75-78, 2020 (ESCI)

Prevalence and characteristics of bone disease in cirrhotic patients

GÖKCAN H., Kayhan M. A., Demir S. O., Kacar S., Cam P., Kaplan M., et al.

HEPATOLOGY FORUM , vol.1, no.2, pp.48-52, 2020 (ESCI)

Mallory-Weiss Sendromunda Tanı, Klinik Seyir ve Endoskopik Tedavi

Gökcan H.

Endoskopi Gastrointestinal , vol.26, no.2, pp.41-45, 2018 (Peer-Reviewed Journal)

Primer Biliyer Kolanjit Hastalarında Tedaviye Yanıt Kriterlerinin Değerlendirilmesi

YÜKSEL M., YILDIZ H., AKDOĞAN KAYHAN M., Kacar S., KILIÇ Z. M. Y., ÖZTAŞ E., et al.

Akademik Gastroenteroloji Dergisi , vol.16, pp.24-29, 2017 (Peer-Reviewed Journal)

Primer sklerozan kolanjiti taklit eden otoimmün kolanjiyopati: Vaka sunumu

Akpınar M. Y., Ödemiş B., Kacar S., GÖKCAN H., KUZU U. B.

Akademik Gastroenteroloji Dergisi , 2016 (Peer-Reviewed Journal)

Porcelain Gallbladder

Akpınar M. Y., KAPLAN M., GÖKCAN H., Erkan V., KAYAÇETİN E.

Akademik Gastroenteroloji Dergisi , 2016 (Peer-Reviewed Journal)

Metastases of malignant melanoma to stomach

Kuzu U. B., Suna N., Gokcan H., Abdullazade S., Oztas E., Odemis B.

GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY , vol.11, no.1, pp.54-55, 2016 (ESCI)

Hepatit C’li hastalarda ortalama trombosit hacmi ve nötrofil-lenfosit oranının anlamlı fibrozis tanısında etkinliği

KUZU U. B., ÖZTAŞ E., SUNA N., Sırtaş Z., YILDIZ H., Akpınar M. Y., et al.

Akademik Gastroenteroloji Dergisi , 2015 (Peer-Reviewed Journal)

Herediter Hemochromatozis

SÜMER H., ŞİMŞEK H., TATAR G.

Türkiye Klinikleri Journal Of Microbiology-Infection (kronik hepatit özel sayısı) , vol.2, no.3, pp.184-194, 2003 (Peer-Reviewed Journal)

Refereed Congress / Symposium Publications in Proceedings

Familial NAFLD Cirrhosis Case Series

AKARCA H. T., GÖKCAN H., GÜVENİR S. T., YILMAZ V., İDİLMAN R.

19. Euroasian Hepatogastroenterology and Surgery, 13 November 2023

Gastric bronchogenic cyst mimicking pancreatic mucinous cyst

duran o. f., GÖKCAN H., KACAR S., AKDOĞAN KAYHAN M., BOSTANCI E. B.

19. Euroasian Hepatogastroenterology and Surgery, 13 November 2023

Case series of C282Y mutation in the HFE gene in Turkey: Single-center experience

BODAKÇİ E., GÖKCAN H., güvener t., YILMAZ V., ER R. E., KARAKAYA M. F., et al.

19. Euroasian Hepatogastroenterology and Surgery, 13 November 2023

noninvazive fibrosis markers for assesment for liver fibrosis in patients with chronic hepatitis delta

KARAKAYA M. F., KURU ÖZ D., Turan Gökçe D., DUMAN S., Ellik Z. M., GÜMÜŞSOY M., et al.

AASLD 2023 congress, 10 November 2023

NON - INVASIVE FIBROSIS MARKERS FOR ASSESMENT OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS DELTA

BODAKÇİ E., KARAKAYA M. F., KURU ÖZ D., Gokce D. T., DUMAN S., Ellik Z. M., et al.

Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 10 - 14 November 2023

development of Metabolik disorders in Liver transplant recepients

Erdemir G., GÖKCAN H., İDİLMAN R.

The 2023 International congress of ILTS ELITA and LICAGE, 03 May 2023

A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.

DUMAN S., KURU ÖZ D., GÜMÜŞSOY M., KİREMİTCİ S., GÖKCAN H., ÖZERCAN A. M., et al.

AASLD-TASL hepatology connect meeting, 28 - 29 April 2023

effect of prognostic tests on disease outcome of alcohol-related liver disease

zengin b. a., GÜMÜŞSOY M., DUMAN S., BODAKÇİ E., ÖZERCAN A. M., ER R. E., et al.

AASLD-TASL hepatology connect meeting, 28 April 2023

Development of Metabolic Disorders in Transplant Recepients

erdemir g., GÖKCAN H., GÜRSOY ÇORUH A., GÜMÜŞSOY M., DUMAN S., İDİLMAN R.

AASLD-TASL hepatology connect meeting, 28 - 29 April 2023

A case of AFP producing cholangiocarcinoma

BODAKÇİ E., GÜMÜŞSOY M., GÜVENİR S. T., KARAKAYA F., GÖKCAN H., İDİLMAN R.

AASLD-TASL hepatology connect meeting, 28 - 29 April 2023

Natural Disease outcome in patients with NAFLDÇ a study with paired liver biopsies

GÜMÜŞSOY M., TURAN D., ekelik m., KİREMİTCİ S., DUMAN S., GÜVENİR S. T., et al.

AASLD-TASL hepatology connect meeting, 28 April 2023

İdentification of risk factors for alcohol relapse in liver transplant patients with alcohol- related liver disease.

TURAN D., GÜNŞAR F., harputluoğlu m., KABAÇAM G., GÖKCAN H., AKARSU M., et al.

EASL Congress 21-24 June 2023, 21 April 2023

Natural disease Outcome in patients with NAFLD: A study with paired liver biopsy

GÜMÜŞSOY M., Turan Gökçe D., KİREMİTCİ S., BODAKÇİ E., DUMAN S., MELEKOĞLU ELLİK Z., et al.

aasld 2022, 04 November 2022

Metabolic Syndrome in liver Transplant recipient

KARA G., GÖKCAN H., İDİLMAN R.

AASLD 2022, 4 - 08 November 2022

Trends and causes of etiology in adult liver transplant patients: multicenter study

AKARSU M., Harputluoğlu M., YILMAZ S., GENÇDAL G., AKYILDIZ M., DİNÇER D., et al.

ınternational Liver congress ILC 2022 (EASL), 22 - 26 June 2022

Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patients with hepatitis B virus related cirrhosis

YAPALI S., GÖKCAN H., DURAK S., MELEKOĞLU ELLİK Z., ADANIR H., GÜNDÜZ F. F., et al.

ınternational Liver congress ILC 2022 (EASL), 22 - 26 June 2022

Preliminary Results of The effectiveness and safety of Tenofovir alafenamide Fumarate Prophylaxis in HBV individuals, who received Chemo/Immunsupression therapy

GÜNDÜZ F. F., DURAK S., ÜNSAL Y., DEMİR M., MELEKOĞLU ELLİK Z., YILDIRIM A. E., et al.

ınternational Liver congress ILC 2022 (EASL), 22 June 2022

The effect of clinicopathologic findings of hepatocellüler carcinoma on post transplant survival: a multicenter cohort from TASL Liver transplantation special group

AKYILDIZ M., GENÇDAL G., İNCE V., ZEYTÜNLÜ M., TURAN İ., GÜNŞAR F., et al.

ınternational Liver congress ILC 2022 (EASL), 22 - 26 June 2022

Effectiveness of MRI methods in the asssement of hepatic steatosis in living liver donors

KURU ÖZ D., MELEKOĞLU ELLİK Z., GÜRSOY ÇORUH A., GÜMÜŞSOY M., DUMANLI S., ER R. E., et al.

ınternational Liver congress ILC 2022 (EASL), 22 June 2022

Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in liver transplant recipients: a multicenter study

GÖKCAN H., YAPALI S., MELEKOĞLU ELLİK Z., GÖKÇEN P., ADANIR H., DURAK S., et al.

ınternational Liver congress ILC 2022 (EASL), 22 - 26 June 2022

Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in liver transplant recipients: A multicenter study

YAPALI S., GÖKCAN H., MELEKOĞLU ELLİK Z., GÖKÇEN P., ADANIR H., DURAK S., et al.

ILTS 2022, 04 May 2022

Biliary complications and management in liver transplant recipients with duct to duct anastomosis: A single center experience

KARAKAYA M. F., ÇINAR K., ER R. E., KIRIMKER E. O., BALCI D., ÖZERCAN A. M., et al.

AASLD-TASL Digital Hepatology Meeting, 14 January 2022